BackEvents

Akros SCHK HK-Global Quality Factor Index

TickerASHGQLT
CurrencyHKD

Sentiment Summary

Positive
8
Neutral
9
Negative
0

Recent Events

7/30/2026, 12:00:00 AM
KLA Corp (KLAC)
Earnings Release

Next quarterly earnings release is expected on or around July 30, 2026; a >1% impact is estimated, expected.

7/30/2026, 12:00:00 AM
Mastercard Inc (MA)
Earnings Release

Mastercard is expected to release its Q2 2026 financial results on July 30, 2026, based on past reporting schedules; earnings releases typically drive price movements of at least 1%, expected

6/16/2026, 12:00:00 AM
Mastercard Inc (MA)
Other

Mastercard's 2026 Annual Stockholder Meeting is scheduled to be held virtually on June 16, 2026; routine meetings generally result in at least a 1% price impact, scheduled

6/12/2026, 12:00:00 AM
KLA Corp (KLAC)
Trading Issue

A ten-for-one forward stock split will become effective on June 12, 2026, with shares scheduled to begin trading on a split-adjusted basis; a >10% impact is estimated for this Trading Issue, scheduled.

6/8/2026, 12:00:00 AM
Apple Inc (AAPL)
Other

Apple's Worldwide Developers Conference (WWDC) keynote is scheduled for 2026-06-08, where major software updates including iOS 27 and significant AI advancements under the "Apple Intelligence" platform are expected. This event is expected to have a high impact (>=10%) due to the strategic importance of AI integration and is expected.

An online investor briefing to discuss Q1 2026 financial results is scheduled for May 21, 2026; low impact (>=1%) estimated as it is a routine informational event scheduled.

5/20/2026, 12:00:00 AM
NVIDIA Corporation (NVDA)
Earnings Release

NVIDIA is scheduled to report its financial results for the first quarter of fiscal year 2027 after the market close on May 20, 2026. Analysts forecast revenue around $79 billion and EPS of $1.78. High importance is estimated based on the 8-10% move priced by options markets scheduled.

5/20/2026, 12:00:00 AM
GE Vernova Inc (GEV)
Other

2026 Annual General Meeting of shareholders scheduled for 2026-05-20. An activist investor group is set to present a proposal criticizing the financial returns of the company's wind power segment scheduled. This event is estimated to have a 1-3% price impact.

NMPA approval for ω-3 Triglycerides/Fat Emulsion/Amino Acids/Glucose injection on May 19, 2026, scheduled. Low importance is estimated as this is a routine product approval for a non-core therapy.

5/19/2026, 12:00:00 AM
GE Vernova Inc (GEV)
Other

Announced the declaration of a third-quarter 2026 dividend of $0.50 per share on 2026-05-19, payable on July 14, 2026, to shareholders of record as of June 16, 2026 expected. This routine announcement is estimated to have a 1-2% price impact.

5/18/2026, 12:00:00 AM
KLA Corp (KLAC)
Other

Ex-dividend date on May 18, 2026, for a quarterly cash dividend of $2.30 per share, representing a 21% increase; a >5% impact is estimated, scheduled.

5/18/2026, 12:00:00 AM
Mastercard Inc (MA)
Other

On May 18, 2026, Mastercard announced an expanded strategic partnership with JD.com focusing on payments innovation, AI-driven commerce, and cross-border connectivity; this partnership is estimated to have a price impact of at least 1%.

Other

Announced on May 15, 2026, the full acquisition of electric pickup truck brand Radar Auto for approximately CNY 218 million. Low importance due to the small acquisition size relative to total revenue.

Other

Final dividend of HKD 1.08 per share for the year ended December 31, 2025, with the ex-dividend date on May 15, 2026, scheduled. This is estimated to have a low impact as dividend amounts are typically anticipated by the market.

5/14/2026, 12:00:00 AM
WuXi AppTec Co Ltd (2359)
Other

Announced the issuance of USD-settled zero-coupon convertible bonds due 2027 with a principal amount of RMB 6.78 billion on 2026-05-14. The net proceeds of approximately USD 1.023 billion will be used for global capacity expansion and general corporate purposes. High importance estimated due to the significant scale of the capital raise and potential dilution scheduled.

Other

Final dividend for 2025 with ex-dividend date on 2026-05-14. The dividend is HKD 1.36953 per H-share, payable on June 12, 2026.

NMPA approval for clinical trials for SHR-3821 injection and other drugs on May 13, 2026, scheduled. Low importance is estimated as clinical trial starts have limited immediate price impact.

By Event Type